等待开盘 04-01 09:30:00 美东时间
+0.028
+3.40%
Gainers Netclass Technology (NASDAQ:NTCL) stock moved upwards by 39.9% to $0.4...
03-18 05:12
Combines Kandi's manufacturing scale, HawkRobo's advanced AI robotics, and established distribution channels to capitalize on the rapidly growing North American autonomous security marketAppoints former Hikvision North
03-17 16:05
Rackspace Technology and Uniphore have formed a strategic partnership to deliver the industry's first Infrastructure-to-Agents architecture as an outcomes-based service. This collaboration aims to enable enterprises to transition AI from experimentation to production at scale while maintaining governance, security, and control. The partnership combines Uniphore's Business AI Cloud with Rackspace's private cloud infrastructure, offering advanced i...
03-10 12:15
Raymond Realty Limited ( ($IN:RAYMONDREL) ) just unveiled an update. Raymond Re...
03-09 14:25
RosCan Gold ( ($TSE:ROS) ) just unveiled an update. Roscan Gold has released a ...
03-03 01:09
Two Mobileum executives, Andrew Warner and Kishore Vangipuram, are being charged with conspiracy to commit securities and wire fraud.
02-19 04:40
Rackspace Technology and Palantir Technologies partner to accelerate AI deployments, offering cloud hosting, data migration, and governed operations for regulated industries. The collaboration reduces deployment time from years to months, with 30 Palantir-trained engineers scaling to 250, aiding businesses to achieve measurable outcomes with AI.
02-18 13:15
Rackspace Technology Inc. to Announce Fourth Quarter 2025 Earnings Rackspace Technology Inc. will announce its fourth quarter 2025 earnings on February 26, 2026. Financial results will be released at 8 am ET on the company's [IR website](https://ir.rackspace.com/news-and-events/events-and-presentati
02-11 05:08
FDA verweigert Zulassung für Regenxbios RGX-121 aufgrund fehlender Wirksamkeitsnachweise REGENXBIO Inc. hat von der US-Arzneimittelbehörde FDA einen Complete Response Letter (CRL) für den Zulassungsantrag (BLA) seines Gentherapie-Kandidaten RGX-121 zur Behandlung von Mucopolysaccharidose Typ II (MPS
02-10 19:05
Hovnanian Enterprises Inc. gibt Termin für Aktionärstreffen bekannt Hovnanian Enterprises Inc. hält am 9. Februar 2026 eine Hauptversammlung ab. Zur Abstimmung stehen die Wahl der vorgeschlagenen Kandidaten für den Verwaltungsrat, die Genehmigung des Fourth Amended and Restated 2020 Hovnanian Enterp
02-10 05:33